Ledger.Open graph →

SEC Form D · Amendment · filed May 10, 2024

MAINZ BIOMED N.V

Offering

$50.0M

Sold

$14.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

MAINZ, 2M

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Moritz Eidens · Mainz, 2MExec · Director Alberto Libanori · Mainz, 2MDirector William Caragol · Mainz, 2MExec Nicole Holden · Mainz, 2MDirector Guido Baechler · Mainz, 2MExec · Director Darin Leigh · Mainz, 2MExec Hans Hekland · Mainz, 2MDirector Gregory Tibbits · Mainz, 2MDirector Phillip Freese · Mainz, 2MExec Heiner Dreismann · Mainz, 2MDirector Heiner Dreismann · Mainz, 2MDirector Gregory Tibbits · Mainz, 2MDirector Nicole Holden · Mainz, 2MDirector Darin Leigh · Mainz, 2MExec William Caragol · Mainz, 2MExec Phillip Freese · Mainz, 2MExec Moritz Eidens · Mainz, 2MExec · Director Guido Baechler · Mainz, 2MExec · Director Alberto Libanori · Mainz, 2MDirector Hans Hekland · Mainz, 2MDirector Romi Mahajan · Bellevue, WAExec · Director Regina Reale · NEW YORK, NYExec · Director Swadesh Mahajan · Austin, TXDirector Mike Kotschenreuther · Cedar Park, TXExec Christopher C. Maguire · Dallas, TXDirector Robert C. Dozier · Dallas, TXDirector Scott C. Harrington · Dallas, TXDirector Brian C. Parro · Dallas, TXDirector Ellen Terchila · Vancouver, Z4Exec Christian Salem · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗